David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
901
DELISTED
Golden Ocean Group
GOGL
| $17.8M | 0.02% |
1,369,606
+1,076,035
| +367% | +$12.4M |
|
902
Resideo Technologies
REZI
$2.97B
| $17.7M | 0.02% |
791,645
-30,843
| -4% | -$609K |
|
903
RxSight
RXST
$258M
| $17.7M | 0.02% |
342,980
+144,410
| +73% | +$7.09M |
|
904
IQVIA
IQV
$42.7B
| $17.6M | 0.02% |
69,744
+67,744
| +3,387% | +$15.8M |
|
905
PUT
Eaton
ETN
$161B
| $17.6M | 0.02% |
56,400
+46,000
| +442% | +$12.6M |
|
906
Builders FirstSource
BLDR
$7.51B
| $17.6M | 0.02% |
84,544
-7,730
| -8% | -$1.43M |
|
|
NVO
907
Novo Nordisk
NVO
$213B
| $17.5M | 0.02% |
136,673
+97,376
| +248% | +$11.6M |
|
908
Carrier Global
CARR
$48.7B
| $17.5M | 0.02% |
301,726
+229,428
| +317% | +$12.9M |
|
909
Prudential Financial
PRU
$40.9B
| $17.4M | 0.01% |
148,242
+65,145
| +78% | +$7.02M |
|
910
Comcast
CMCSA
$96.7B
| $17.4M | 0.01% |
401,420
+267,172
| +199% | +$11.5M |
|
|
YMAB
911
DELISTED
Y-mAbs Therapeutics
YMAB
| $17.4M | 0.01% |
1,068,159
-255,621
| -19% | -$3.45M |
|
|
SNBR
912
DELISTED
Sleep Number
SNBR
| $17.4M | 0.01% |
1,082,624
-4,341
| -0.4% | -$56.3K |
|
913
SM Energy
SM
$8.56B
| $17.3M | 0.01% |
347,944
-242,140
| -41% | -$9.9M |
|
|
SHYF
914
DELISTED
The Shyft Group
SHYF
| $17.3M | 0.01% |
1,392,964
+64,345
| +5% | +$717K |
|
915
CALL
SLB Ltd
SLB
$79.7B
| $17.3M | 0.01% |
315,100
-18,000
| -5% | -$907K |
|
916
InterDigital
IDCC
$8.82B
| $17.2M | 0.01% |
161,685
-236,739
| -59% | -$25M |
|
917
Moog Inc Class A
MOG.A
$12B
| $17.1M | 0.01% |
107,138
-19,289
| -15% | -$2.84M |
|
918
PUT
BioNTech
BNTX
$29.1B
| $17.1M | 0.01% |
185,300
+700
| +0.4% | +$67.1K |
|
919
PUT
Twilio
TWLO
$34.3B
| $17.1M | 0.01% |
279,100
-443,700
| -61% | -$29.2M |
|
920
CACI
CACI
$13.6B
| $17.1M | 0.01% |
45,011
-5,408
| -11% | -$1.92M |
|
921
PUT
AbbVie
ABBV
$470B
| $17M | 0.01% |
93,300
-333,800
| -78% | -$57.5M |
|
|
ALPN
922
DELISTED
Alpine Immune Sciences Inc
ALPN
| $17M | 0.01% |
428,555
+133,013
| +45% | +$3.92M |
|
923
Federated Hermes
FHI
$4.85B
| $17M | 0.01% |
469,396
-410,663
| -47% | -$14.4M |
|
924
Thomson Reuters
TRI
$45.5B
| $16.9M | 0.01% |
107,113
-41,639
| -28% | -$6.48M |
|
925
Axos Financial
AX
$5.53B
| $16.9M | 0.01% |
313,414
-32,683
| -9% | -$1.72M |
|
Similar funds
David Shaw's Q1 2024 Portfolio in Review
As of Q1 2024, David Shaw held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Arm worth $297M.
- David Shaw's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- David Shaw added most to Apple in Q1 2024, an estimated $820M increase.
- David Shaw's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- David Shaw fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- David Shaw's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- David Shaw opened 655 new positions and closed 634 in Q1 2024.
- David Shaw's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.